DRESS/DIHS syndrome induced by sulfasalazine
https://doi.org/10.18093/0869-0189-2021-31-6-822-826
Abstract
Among the manifestations of drug hypersensitivity, DRESS/DIHS syndrome is of particular importance. The clinical manifestations include rash, enlarged lymph nodes, fever, hepatitis, leukocytosis with eosinophilia, as well as the involvement of other organs and systems. The most common causative agents include anticonvulsants, antidepressants, sulfanilamides, non-steroidal anti-inflammatory drugs, and allopurinol, but the list is constantly expanding. The exact pathogenesis of DRESS/DIHS syndrome is currently unclear. Timely diagnosis and adequate therapy can improve prognosis of this disease. In our clinical case, DRESS syndrome developed after the patient was administered sulfasalazine for erosive proctosigmoiditis. In order to ensure adequate prevention, early diagnosis, and proper management of DRESS syndrome, it is necessary to raise awareness of practitioners of different specialties about the possibility of developing this undesirable reaction to pharmacotherapy.
About the Authors
Irina V. DemkoRussian Federation
Doctor of Medicine, Professor, Head of Department of Internal Medicine and Immunology with a course of postgraduate education, Prof. V.F.Voino-Yasenetsky Krasnoyarsk SMU; Head of Pulmonary Allergology Center, MDD, RSBHIRCH.
Ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022; ul. Partizana Zheleznyaka 3А, Krasnoyarsk, 660022; tel.: (913) 507-84-08
Competing Interests:
no
Elena A. Sobko
Russian Federation
Doctor of Medicine, Professor, Department of Internal Medicine and Immunology with a course of postgraduate education, Prof. V.F.Voino-Yasenetsky Krasnoyarsk SMU; Head of the Department of Allergology, MDD, RSBHIRCH.
Ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022; ul. Partizana Zheleznyaka 3А, Krasnoyarsk, 660022; tel.: (923) 327-11-92
Competing Interests:
no
Olga P. Ischenko
Russian Federation
Candidate of Medicine, Assistant, Department of Internal Medicine and Immunology with a course of postgraduate education, Prof. V.F.Voino-Yasenetsky Krasnoyarsk SMU; Allergist, MDD, RSBHIRCH.
Ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022; ul. Partizana Zheleznyaka 3А, Krasnoyarsk, 660022; tel.: (908) 207-32-17
Competing Interests:
no
Angelina Yu. Kraposhina
Russian Federation
Angelina Yu. Kraposhina, Candidate of Medicine, Associate Professor, Department of Internal Medicine and Immunology with a course of postgraduate education Prof. V.F.Voino-Yasenetsky Krasnoyarsk SMU; Pulmonologist, MDD, RSBHIRCH.
Ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022; ul. Partizana Zheleznyaka 3А, Krasnoyarsk, 660022; tel.: (902) 990-37-67
Competing Interests:
no
Larisa V. Aristarchova
Russian Federation
Allergist, Department of Allergology.
Ul. Partizana Zheleznyaka 3А, Krasnoyarsk, 660022; tel.: (913) 046-97-89
Competing Interests:
no
Natalia V. Gordeeva
Russian Federation
Candidate of Medicine, Associate Professor, Department of Internal Medicine and Immunology with a course of postgraduate education, Prof. V.F.Voino-Yasenetsky Krasnoyarsk SMU; Pulmonologist, MDD, RSBHIRCH.
Ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022; ul. Partizana Zheleznyaka 3А, Krasnoyarsk, 660022; tel.: (913) 199-06-53
Competing Interests:
no
Anna S. Deyhina
Russian Federation
Clinical Resident, Department of Internal Medicine and Immunology with a course of postgraduate education.
Ul. Partizana Zheleznyaka 1, Krasnoyarsk, 660022; tel.: (983) 162-28-46
Competing Interests:
no
References
1. Mori F., Caffarelli C., Caimmi S. et al. Drug reaction with eosin-ophilia and systemic symptoms (DRESS) in children. Acta Biomed. 2019; 90 (3): 66-79. DOI: 10.23750/abm.v90i3-S.8167.
2. Husain Z., Reddy B.Y., Schwartz R.A. DRESS syndrome: Part I. Clinical perspectives. J. Am. Acad. Dermatol. 2013; 68 (5): 693.e1-693.e14. DOI: 10.1016/j.jaad.2013.01.033.
3. Ganeva M., Gancheva T., Lazarova R. et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int. J. Dermatol. 2008; 47 (8): 853-860. DOI: 10.1111/j.1365-4632.2008.03637.x.
4. Mizukawa Y., Hirahara K., Kano Y., Shiohara T. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease. J. Am. Acad. Dermatol. 2019; 80 (3): 670-678.e2. DOI: 10.1016/j.jaad.2018.08.052.
5. Waseem D., Latief M., Sofi N. et al. Dress syndrome: a review and update. Skin Dis. Skin Care. 2016; 1: 1. Available at: https://skin-diseases-and-skin-care.imedpub.com/dress-syndrome-a-review-and-update.php?aid=8747
6. Shiohara T., Iijima M., Ikezawa Z., Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br. J. Dermatol. 2007; 156 (5): 1083-1084. DOI: 10.1111/j.1365-2133.2007.07807.x.
7. Sobko E.A., Demko I.V., Solov’eva I.A. et al. [Clinical effectiveness of allergenspecific immunotherapy]. Sibirskoe meditsinskoe obozre-nie. 2015; 1 (91): 84-90. Available at: https://smr.krasgmu.ru/journal/1059_16.pdf (in Russian).
Review
For citations:
Demko I.V., Sobko E.A., Ischenko O.P., Kraposhina A.Yu., Aristarchova L.V., Gordeeva N.V., Deyhina A.S. DRESS/DIHS syndrome induced by sulfasalazine. PULMONOLOGIYA. 2021;31(6):822-826. (In Russ.) https://doi.org/10.18093/0869-0189-2021-31-6-822-826